Benzinga | May 11, 2021 09:00AM EDT

SVB Leerink Maintains Outperform on Veracyte, Lowers Price Target to $65

SVB Leerink analyst Puneet Souda maintains Veracyte (NASDAQ:VCYT) with a Outperform and lowers the price target from $75 to $65.